ABPI response to Data Strategy publication

The ABPI has responded to publication of the Government's new data strategy

The pandemic has shown us the huge potential NHS data has to accelerate the development of new medicines and vaccines. Colette Goldrick, ABPI Executive Director, Strategy, Research and Partnerships

Colette Goldrick, the ABPI's Executive Director of Strategy, Research and Partnerships, said: 

"The pandemic has shown us the huge potential NHS data has to accelerate the development of new medicines and vaccines.

"The Data Saves Lives Strategy is a landmark moment, and a major step forward in harnessing that potential. For the strategy to be a success it is critical that we operate with complete transparency and engage the public in a meaningful way.

"That is why over the past 5 months we have consulted with the public, patients, and NHS on new principles which will underpin how our industry members use NHS data to drive research and transform lives."

Background 

In February the ABPI launched a public consultation on draft governance principles for industry use of health data, and has since held several one to one sessions with key stakeholders representing patients, clinicians, the research community and the NHS to co-develop these principles.

The principles, due to be launched in the coming weeks, are designed to complement the already robust rules, regulations and guidelines already in place to ensure the safe and secure use of data for research purposes. 

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.